Living with and having a close bond with a companion animal does not necessarily lead to significant mental health improvements in people with a serious mental illness, say researchers.
Alnylam abandons plans for RNAi drug Onpattro after FDA hits the brakes – Pharmaceutical Technology
The CRL is a complete turnaround from the positive recommendation Onpattro received in September from an FDA Advisory Committee (AdCom) panel regarding the label expansion.